Europe — EMA

Palonan Ανφαρμ Ελλασ Α.Ε. (Palonosetron)

Palonosetron, the active ingredient in Palonan Ανφαρμ Ελλασ Α.Ε., is a 5‑HT3 receptor antagonist presented as a unknown/unknown for intravenous use.

Palonosetron

Request sourcing

Pack/s

What is Palonosetron?

Palonosetron, the active ingredient in Palonan Ανφαρμ Ελλασ Α.Ε., is a 5‑HT3 receptor antagonist presented as a unknown/unknown for intravenous use. It treats and prevents chemotherapy‑induced nausea and vomiting in adult oncology patients. GNH USA supplies Palonan Ανφαρμ Ελλασ Α.Ε. as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

GNH USA supplies Palonan Ανφαρμ Ελλασ Α.Ε. as a licensed, GDP‑compliant international pharmaceutical ...

What is Palonosetron used for?

Palonosetron is …

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →